Analyzing data from CVOTs can provide insights into the pathophysiologic mechanisms by which GLP-1RAs are linked to ASCVD and define the use of GLP-1RAs in clinical practice
Singh, A.P., Prabha, V., and Rishi, P., Indian J
Tirzepatide was used at 30 nM and the antagonists were used at 1M concentrations
The experiment was divided into a normal control group, a radiotherapy model group, and a radiotherapy+IGF-1 LR3 treatment group (1mg/kg, orally taken from the first day after radiotherapy, once a day, for 7 consecutive days)
Various compounds were used in order to examine the signaling components of IGF-1, including, tyrosine kinase inhibitors, PI3K inhibitors and LY 294002 inhibitors
Bu tr takviyelerin uygun ekilde kullanlmas iin baz nemli faktrler vardr